KalshiFinancials
FDA decision: Rusfertide by Protagonist Therapeutics (in 2026)
FDA decision on Rusfertide in 2026
Ends Aug 29, 2026
Bet NowDisclosure
18+ only. Event contracts carry significant risk and are not suitable for everyone, you can lose the entire amount you commit. Not available in all jurisdictions; restrictions and eligibility requirements apply.
- a full approval or an accelerated approval2.1K VOL.Yes 98%No 2%98¢
Rules Summary
If the FDA's decision on Rusfertide by Protagonist Therapeutics in 2026 is a full approval or an accelerated approval, the market resolves to Yes.
Timeline and Payout
- Opened
- Jun 17, 2026, 9:00 PM
- Closes
- Aug 29, 2026, 12:33 PM
- Pays out
- 0.5 hours after close
Series KXRUSFERTIDE · Event KXRUSFERTIDE-27 · Market KXRUSFERTIDE-27-Y